Author:
Kohno S-i,Luo C,Nawa A,Fujimoto Y,Watanabe D,Goshima F,Tsurumi T,Nishiyama Y
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference47 articles.
1. Chiocca EA . Oncolytic viruses. Nat Rev Cancer 2002; 2: 938–950.
2. Varghese S, Rabkin SD . Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther 2002; 9: 967–978.
3. Nishiyama Y . Herpes simplex virus gene products: the accessories reflect her lifestyle well. Rev Med Virol 2004; 14: 33–46.
4. Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Therapy 2000; 867–874.
5. Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D et al. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Therapy 2000; 7: 859–866.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献